Who Benefits Most? Patient Selection for Atrial Fibrillation Catheter Ablation in Heart Failure [0.03%]
谁是最大受益者？心力衰竭患者房颤导管消融的患者选择
Aaron A Sifuentes,Mohammed Mhanna,Paari Dominic et al.
Aaron A Sifuentes et al.
AF and heart failure (HF) often coexist, amplifying morbidity and mortality. Catheter ablation is an effective rhythm control strategy, particularly in heart failure with reduced ejection fraction, where studies such as CASTLE-AF show impro...
Roy M John
Roy M John
Nadiya Johal,Badrinathan Chandrasekaran,Paul Foley
Nadiya Johal
Five patients who underwent left bundle branch optimised (LOT)-CRT developed T wave oversensing (TWOS) between 2 months and 2 years post implant. LOT-CRT resulted in greater improvement in left ventricular size and function compared with hi...
Radiofrequency Catheter Ablation for Arrhythmia-induced Cardiomyopathy in Infants: A Case Series and Literature Review [0.03%]
射频导管消融治疗婴幼儿心律失常性心肌病的疗效观察及文献复习
Xuan Li,Wenjuan Shu,Miao Hou et al.
Xuan Li et al.
Radiofrequency catheter ablation (RFCA) is an established treatment for paediatric arrhythmias in children weighing >15 kg, yet its role in infants with arrhythmia-induced cardiomyopathy remains less defined. This case series evaluates the ...
Jude Scott
Jude Scott
Device-detected AF, commonly labelled atrial high-rate episodes or subclinical AF (SCAF), creates a dilemma over anticoagulation: absolute stroke risk will be lowered, yet oral anticoagulation (OAC) carries a real risk of major bleeding. Th...
Ablation Methods and Catheter Settings for Ventricular Tachycardia Ablation: A Bench to Bedside Review: Part 2 [0.03%]
心室颤动消融的消融方法和导管设置：从实验室到临床综述：第2部分
Maria Niespialowska-Steuden,John Silberbauer,Jaffar Al-Sheikhli et al.
Maria Niespialowska-Steuden et al.
Catheter ablation remains a cornerstone in the treatment of ventricular tachycardia (VT) in structural heart disease. Part 1 of this review focused on the principles and technical aspects of radiofrequency (RF) ablation. Part 2 explores alt...
Ablation Methods and Catheter Settings for Ventricular Tachycardia Ablation: A Bench to Bedside Review: Part 1 [0.03%]
室性心动过速消融的消融方法与导管设置：从实验台到临床应用综述（上篇）
Maria Niespialowska-Steuden,John Silberbauer,Jaffar Al-Sheikhli et al.
Maria Niespialowska-Steuden et al.
Catheter ablation is the primary treatment for ventricular tachycardia (VT) in patients with structural heart disease. Unfortunately, its long-term success remains limited. Although mapping techniques have advanced considerably, optimal abl...
Next-generation ICDs: Individualised Selection for Improved Cardiac Outcomes [0.03%]
新一代ICD：个性化选择以改善心脏结局
Lin-Thiri Toon,Christopher Monkhouse,Waqas Ullah et al.
Lin-Thiri Toon et al.
Cardiovascular disease is a major global cause of death, with sudden cardiac death accounting for up to half of cases, largely due to ventricular tachyarrhythmias. In the UK, approximately 60,000 out-of-hospital cardiac arrests occur annual...
Which Patient Benefits from Guideline-directed Medical Therapy for Heart Failure and Rate Control versus Rhythm Control in Patients with Congestive Heart Failure and Atrial Fibrillation and What are Those Therapies? [0.03%]
哪些患者可以从心力衰竭和心动过速的指南指导下的药物治疗中受益而不是从房颤和充血性心力衰患者的节律控制中获益？这些疗法是什么？
Gregory Burkman,Gerald V Naccarelli
Gregory Burkman
The management of AF in patients with heart failure is complex and nuanced. This paper explores the potential antiarrhythmic effects of guideline-directed medical therapy for heart failure and reviews the pharmacological and ablative treatm...
Alan D Enriquez
Alan D Enriquez
The incidence of idiopathic ventricular arrhythmias (VAs) is increasing, and the outflow tract region is the most common site of origin for these arrhythmias. While these arrhythmias are benign, significant symptoms and cardiomyopathy due t...